A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

NCT04857047 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: BR9003 2mg
DRUG: BR9003A 1mg

Sponsor

Boryung Pharmaceutical Co., Ltd